Skip to main content

Find Clinical Trials

Home
Conditions
Vector Borne Diseases

Clinical trial condition

Vector Borne Diseases

Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.

2,038 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Vector Borne Diseases trial results

Completed

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

NCT00161889

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Neuschwanstein Strasse 5 Augsburg, Germany

Marktplatz 33 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

Salzgasse 11 Calw, Germany

View all 19 locations

View Trial Details

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

NCT00161863

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Marktplatz 3 Bad Saulgau, Germany

Solothurner Strasse 2 Heilbronn, Germany

Hauptstraße 240 Kehl, Germany

View Trial Details

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

NCT00161785

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Hospital in Debica - Zespo Opieki Zdrowotnej w Debicy Dębica, Poland

Szpital Jana Pawla II Oddzial Neuroinfekcji Krakow, Poland

View Trial Details

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

NCT00161772

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Neuschwansteinstrasse 5 Augsburg, Germany

Marktplatz 3 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

View all 23 locations

View Trial Details

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

NCT00161967

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Upper Austria, Austria

Hauptstrasse 240 Kehl, Germany

Niepubliczny ZOZ Zamość, Poland

View Trial Details

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

NCT00163540

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: SGS Biopharma Research Unit Stuivenberg Antwerp, Belgium

View Trial Details

Completed

Can Mass Media Campaigns Reduce Child Mortality

NCT01517230

Conditions: Behavior, Breast Feeding, Breastfeeding, +20 more
Locations: Centre Muraz Bobo-Dioulasso, Burkina Faso

View Trial Details

Completed

Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum

NCT01144702

Conditions: Falciparum Malaria, Infections, Malaria, +5 more
Locations: Oswaldo Cruz Foundation Rio de Janeiro, Brazil

Institute of Biomedical Sciences, University of Sao Paulo São Paulo, Brazil

View Trial Details

Completed

Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers

NCT01958619

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Richmond Pharmacology Ltd. Croydon, London, United Kingdom

View Trial Details

Completed

Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State

NCT01853475

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Richmond Pharmacology Limited Croyden, London, United Kingdom

View Trial Details